CVS Health Q1 Profit Tops $2.9 Billion as Aetna Plan Costs Ease

CVS Health reported net income of $2,957 million for the quarter ended March 31, driven by easing costs in the Aetna health plans and favorable development in prior-year health cost estimates.

The company said its Health Care Benefits segment recorded a significant increase in adjusted operating income, with adjusted operating income reported at $3,041 million and the medical benefit ratio (MBR) improving to 84.6% from 87.3 a year earlier. CVS also noted $1.1 billion of favorable prior-period development in health care costs during the quarter.

Revenues across CVS’s operating segments rose year-on-year, supported by pharmacy product mix and growth in government business, while pharmacy client pricing headwinds weighed on adjusted results in parts of its Health Services operations. Consolidated net cash provided by operating activities was $4,249 million, and the company raised its full-year guidance reflecting stronger-than-expected segment performance.

The results arrive as U.S. policy developments, including final Medicare Advantage payment updates from the Centers for Medicare & Medicaid Services (CMS), and industry moves to streamline prior authorization practices, add predictability to insurer performance. CVS highlighted operational improvements in prior authorization processing and continued efforts to automate provider interactions, which management said reduced administrative friction.

Market observers note that while the Aetna-related cost normalization supports near-term earnings, factors such as drug inflation, PBM contract dynamics and claims trends will be key to maintaining momentum. Investors will watch subsequent quarterly updates and guidance adjustments to assess whether the current improvement continues through the remainder of 2026.